Effect of Zinc and Probiotics Supplementation on Laryngeal Cancer Patients Undergoing Laryngectomy Surgery to Improve Prognosis and Better Wound Healing
NCT ID: NCT06674564
Last Updated: 2024-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
140 participants
INTERVENTIONAL
2024-09-09
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT05901779
Effect of Prebiotic and Synbiotic Supplementation in Individuals Undergoing Roux-en-y Gastric Bypass.
NCT02158676
Effect of Probiotics in Patients Undergoing Surgery for Periampullary Neoplasms
NCT01468779
Impact of Symbiotic Administration on Intestinal Function of Head and Neck Patients Surgically Treated
NCT02654652
Beneficial Effects of Probiotics on Improvement of Gut Dysbiosis and Ascending Cholangitis in Patients Received Pancreaticoduodenectomy
NCT06126432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
patients in this group will not having any interventions except the usual treatment before and after surgery
No interventions assigned to this group
zinc group
patients in this group will take 50 mg zinc sulfate beside the usual treatment
Zinc Acetate 50 Mg Oral Capsule
zinc suppose to improve immunity and wound healing after laryngectomy
probiotics group
patients in this group will take probiotics beside the usual treatment
Probiotic
probiotics lowering infections rates and improving outcomes after surgery
zinc and probiotics proup
patients in this group will take zinc and probiotics beside the usual treatment
Zinc Acetate 50 Mg Oral Capsule
zinc suppose to improve immunity and wound healing after laryngectomy
Probiotic
probiotics lowering infections rates and improving outcomes after surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zinc Acetate 50 Mg Oral Capsule
zinc suppose to improve immunity and wound healing after laryngectomy
Probiotic
probiotics lowering infections rates and improving outcomes after surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Patients with Level of hemoglobin \>9 mg/dl and serum albumin 3g/dl According to (Crosetti et al. 2021).
Staging of laryngeal cancer according to the American Joint Committee on Cancer (AJCC) 8th edition by TNM system.
Exclusion Criteria
3.Hypersensitivity to probiotics and zinc.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
botamina nabil
Role: PRINCIPAL_INVESTIGATOR
pharmacy ASU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain shams university hospital
Cairo, Al Abbasya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
zn probiotics laryngeal cancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.